Pseudomyxoma peritonei

Title:

Pseudomyxoma peritonei
Pseudomyxoma peritonei
Pseudomyxoma peritonei

Creator:

Kocián, Roman

Contributor:

Kocián, Roman

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:bmc13009742-71d48711-a071-4781-b7a8-760b074c8831
uuid:bmc13009742-71d48711-a071-4781-b7a8-760b074c8831
local:bmc13009742
http://www.actualgyn.com/pdf/cz_2013_97.pdf
local: bmc13009742

Subject:

lidé, pseudomyxom peritonea--diagnóza--terapie, nádory apendixu, incidence, ženské pohlaví, mužské pohlaví, recidiva, staging nádorů, popis nemoci, kombinovaná terapie, indukovaná hypotermie, protokoly antitumorózní kombinované chemoterapie, algoritmy, výsledek terapie, smrt, přežití, prognóza, and laparotomie

Type:

model:article, article, Text, statistics, and TEXT

Format:

braille, electronic resource, remote, and elektronický zdroj

Description:

Pseudomyxoma peritonei je vzácný klinický syndrom; nádorový proces, pro který je charakteristické hromadění mucinózního ascitu a peritoneálních implantátů v břišní dutině. Primárním zdrojem je téměř vždy low grade mucinózní tumor apendixu. Jedná se o pomalu progredující, nízce agresivní, ale smrtící onemocnění s častými recidivami. Optimálním léčebným postupem je kompletní chirurgická cytoredukce (CRS) v kombinaci s peroperačně aplikovanou intraperitoneální hypertermickou chemoterapií (HIPEC) – tzv. Sugarbakerova metoda., Pseudomyxoma peritonei (PMP) is an uncommon clinical syndrome characterized by the slow and progressive accumulation of peritoneal implants and mucinous ascites, intraabdominal gelatinous collection (jelly belly). PMP is reported to originate from the low grade appendiceal mucinous neoplasm. Pseudomyxoma peritonei often recurs after treatment and may eventually cause death by abdominal visceral dysfunction via compression with mucinous ascites. Cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy comprising hyperthermic intraperitoneal chemotherapy (HIPEC) with or without postoperative intraperitoneal chemotherapy (EPIC) has been regarded as the standard of care in specialized centers. It is often referred to as the „Sugerbaker procedure“. Conventionally, PMP is considered resistant to systemic chemotherapy. Even though complete cytoreduction is associated with prolonged overall survival, recurrence of disease is common and multiple operations are frequently required. Patients may enjoy sustained period of remission, free of symptoms, but long – term disease free survival is distinctly uncommon. The pathologic subtype remains the dominant factor in survival. Patients should be centralized to improve survival by a combination of surgical experience and adequate patient selection., Roman Kocián, and Literatura

Language:

Czech and English

Rights:

http://creativecommons.org/publicdomain/mark/1.0/
policy:public

Relation:

Aktuální gynekologie a porodnictví--MED00165192

Source:

Aktuální gynekologie a porodnictví: recenzovaný on-line časopis | 2013 Volume:5

Harvested from:

CDK

Metadata only:

false

Date:

2013